Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 6Unknown 1Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma 9Hodgkin Disease 7Testicular Neoplasms 3Teratoma 3Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Ovarian Neoplasms 2Ovarian Germ Cell Cancer 2Warts 1Vulvar Neoplasms 1Testicular Germ Cell Tumor 1Stomach Neoplasms 1Sertoli-Leydig Cell Tumor 1Seminoma 1Sarcoma, Kaposi 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Processes 1Ovarian gynandroblastoma 1Neoplastic Processes 1Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Intracranial Non-germinomatous Germ Cell Tumor 1Head and Neck Neoplasms 1HIV Infections 1Granulosa cell tumor of the ovary 1Germinoma 1Endodermal Sinus Tumor 1

Interventions

Paclitaxel 2Filgrastim 2Cisplatin 2pegfilgrastim 1Lenograstim 1Ifosfamide 1Gemcitabine 1Etoposide 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Endodermal Sinus Tumor × Bleomycin × Clear all
NCT00003643 2012-03-06

Combination Chemotherapy in Treating Men With Germ Cell Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Unknown
498 enrolled
Genitourinary

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡